Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects.
about
Developmental consequences of perinatal cannabis exposure: behavioral and neuroendocrine effects in adult rodentsA genome-wide RNAi screen in Caenorhabditis elegans identifies the nicotinic acetylcholine receptor subunit ACR-7 as an antipsychotic drug targetAltering endocannabinoid neurotransmission at critical developmental ages: impact on rodent emotionality and cognitive performance.In utero antiepileptic drug exposure: fetal death and malformationsIn vitro blood-brain barrier models using brain capillary endothelial cells isolated from neonatal and adult rats retain age-related barrier properties.Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.Prenatal antipsychotic exposure and neuromotor performance during infancy.Cognitive/behavioral teratogenetic effects of antiepileptic drugs.Adverse effects of oral nonstimulant psychotropic medications in young children reported to a regional poison center.Zebrafish as a systems toxicology model for developmental neurotoxicity testing.Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database.Antenatal maternal antidepressants drugs affect Activin A concentrations in maternal blood, in amniotic fluid and in fetal cord blood.Behavioral characteristics and cognitive development among school age children born to women with epilepsy.Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and effects on the fetus and newborn: a meta-analysis.Structural covariance networks of striatum subdivision in patients with Parkinson's disease.Effect of in utero exposure to the atypical anti-psychotic risperidone on histopathological features of the rat placenta.
P2860
Q24613945-7BC0D290-78E4-4BB2-AF8F-20279CF54E4DQ28487183-982DE2BB-F3BF-4691-8C0D-0BA2A0E2F910Q30471167-D877A5E5-2130-4155-A380-9E7561513520Q34555052-0499D5DA-E582-4AD9-8B9F-D1BFFD296202Q34576146-E408A243-3228-48FA-AA30-CDC3A80B4B6BQ35090255-F72471D3-B23B-4D5F-881B-F15FF1685A0FQ36467152-D0D04388-263C-453F-AC55-B4B7994CDFEFQ36998336-EBEE681E-687B-4648-801D-4BC06DB854D3Q37880889-23953B32-9ECE-440E-B3C5-2938A26B5706Q38238589-118B5DF8-A6DA-4CA3-A8F9-A000EFF54088Q39846163-956C9318-455B-4051-874C-2C4B4CE61687Q42609484-A330179F-45BA-4E74-9816-C0D786ABA41DQ45416702-55C60EAD-1AAB-420D-AD4A-DD047F00EF9CQ46599065-E2BADDB2-60DD-4067-ADB6-F02D959031D4Q48374033-A81A09B8-3C43-4B96-AB22-4CC74A2A5771Q52672209-CF5EA4B0-6C32-4238-AE1E-F1B50FF03C73
P2860
Structural effects and neurofunctional sequelae of developmental exposure to psychotherapeutic drugs: experimental and clinical aspects.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Structural effects and neurofu ...... rimental and clinical aspects.
@ast
Structural effects and neurofu ...... rimental and clinical aspects.
@en
type
label
Structural effects and neurofu ...... rimental and clinical aspects.
@ast
Structural effects and neurofu ...... rimental and clinical aspects.
@en
prefLabel
Structural effects and neurofu ...... rimental and clinical aspects.
@ast
Structural effects and neurofu ...... rimental and clinical aspects.
@en
P2093
P356
P1476
Structural effects and neurofu ...... rimental and clinical aspects.
@en
P2093
Luca Steardo
Lucio G Costa
Vincenzo Cuomo
P304
P356
10.1124/PR.56.1.5
P577
2004-03-01T00:00:00Z